Loading...

Propidium Iodide Solution

Pricing & Availability
Regulatory Status
RUO
Other Names
PI
Ave. Rating
Submit a Review
Product Citations
publications
See Propidium Iodide spectral data
Cat # Size Price Quantity Check Availability Save
421301 2 mL 44€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Propidium iodide (PI) is a fluorescent dye that binds to DNA. When excited by 488nm laser light, it can be detected with in the PE/Texas Red® channel with a bandpass filter 610/10. It is commonly used in evaluation of cell viability or DNA content in cell cycle analysis by flow cytometry.

Product Details
Technical Data Sheet (pdf)

Product Details

Formulation
Phosphate-buffered saline, pH 7.2, containing 0.09% sodium azide.
Concentration
0.5 mg/ml
Storage & Handling
The solution should be stored undiluted between 2°C and 8°C, and protect from light. Caution: This solution contains hazardous material; handle with care.
Application

FC - Quality tested
Recommended Usage

The suggested use of this solution for viability staining is 10 µl per million cells in 0.5 ml/test, and incubate for 15 minutes at 4 °C before analysis. For Cell Cycle analysis, please see our Propidium Iodide Cell Cycle Staining Protocol. Caution: This solution is toxigenic and mutagenic; handle with care.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Propidium Iodide Solution can be used in evaluation of apoptosis, cell viability and cell cycle analysis by flow cytometry.

Application References
  1. Vermes I, et al.1995. J. Immunol. Methods 184:39.
  2. Darzynkiewicz Z, et al. 1992. Cytometry 13(8):795.
  3. Douglas RS, et al. 1995. J. Immunol. Methods 188:219.
  4. Sakimoto I, et al. 2006. Cancer Research 66:2287.PubMed
  5. Liu H, et al. 2012. Int J Biochem Cell Biol. 45:408. PubMed
  6. Juel HB, et al. 2013. PLoS One. 8:64619. PubMed
  7. Ren Q, et al. 2013. PLoS One. 8:74732. PubMed
  8. Zhao W, et al. 2013. Clin Immunol. 149:119. PubMed
  9. Beggs KM, et al. 2014. Toxicol Sci. 137:91. PubMed
  10. Ewald SE, et al. 2014. Infect Immun. 82:460. PubMed
  11. Tsou WI, et al. 2014. J Biol Chem. 289:25750. PubMed
  12. Kong S, et al. 2014. J Immunol. 193:5515. PubMed
Product Citations
  1. Glynn RA, et al. 2022. J Immunol. 208:371. PubMed
  2. Marques de Menezes EG, et al. 2022. MBio. 13:e0300521. PubMed
  3. Das Gupta D, et al. 2022. Cell Death Differ. 29:2163. PubMed
  4. Qin L, et al. 2022. Sci Adv. 8:eabn3774. PubMed
  5. Cheng Y, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:964. PubMed
  6. Choi UY, et al. 2022. Cell Rep. 40:111234. PubMed
  7. Park J, et al. 2022. Animals (Basel). 12: . PubMed
  8. Papakonstantinou A, et al. 2022. Int J Mol Sci. 24: . PubMed
  9. Blal K, et al. 2023. Cancers (Basel). 15: . PubMed
  10. Xiong E, et al. 2023. Front Immunol. 13:1083119. PubMed
  11. Tanaka T, et al. 2023. Nat Immunol. 24:439. PubMed
  12. Bhardwaj M, et al. 2023. J Clin Invest. :. PubMed
  13. Hochrein SM, et al. 2022. Cell Metab. 34:516. PubMed
  14. Wenes M, et al. 2022. Cell Metab. 34:731. PubMed
  15. Li W, et al. 2019. Aging (Albany NY). 0.99375. PubMed
  16. Evans SJ, et al. 2022. Toxicol In Vitro. 83:105415. PubMed
  17. Hagege A, et al. 2022. Cell Rep Med. 3:100659. PubMed
  18. Tintelnot J, et al. 2023. Nature. 615:168. PubMed
  19. Ohuchi K, et al. 2023. Biomed Rep. 18:28. PubMed
  20. Quintela M, et al. 2023. Clin Epigenetics. 15:63. PubMed
  21. Buckley MT, et al. 2023. Nat Aging. 3:121. PubMed
  22. Quintela M, et al. 2023. Br J Cancer. . PubMed
  23. Sohrabi N, et al. 2023. Iran J Public Health. 52:633. PubMed
  24. Papsdorf K, et al. 2023. Nat Cell Biol. 25:672. PubMed
  25. Schwartz PB, et al. 2023. PLoS Genet. 19:e1010770. PubMed
  26. Wyrobnik I, et al. 2023. Oncoimmunology. 12:2219164. PubMed
  27. Z¡rybnick½, T., Lindfors, S., et al. 2025. FEBS J. 292(23),6365-6399. PubMed
  28. Yu, D., Kim, L., et al. 2025. Poult Sci. 104(11),105875. PubMed
  29. Nelson, C. E., Kauffman, K. D., et al. 2025. iScience. 28(12),114034. PubMed
  30. Liu H, et al. 2012. Int J Biochem Cell Biol. 45:408. PubMed
  31. Ewald S, et al. 2014. Infect Immun . 82:460. PubMed
  32. Guo H, et al. 2016. Sci Rep. 6:37559. PubMed
  33. Smith A, et al. 2017. Sci Rep. 7:41872. PubMed
  34. Lindqvist B, et al. 2022. PLoS Pathog. 18:e1010555. PubMed
  35. Chan J, et al. 2017. Oncogene. 10.1038/onc.2017.319. PubMed
  36. Uroda T, et al. 2019. Mol Cell. 75:982. PubMed
  37. Hamel Y, et al. 2021. Cell Rep Med. 2:100370. PubMed
  38. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  39. Leeth C, et al. 2021. Animals (Basel). 11:. PubMed
  40. Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
  41. McNeal AS, et al. 2021. Elife. 10:. PubMed
  42. Neumann CKA, et al. 2020. Mol Metab. 34:136. PubMed
  43. Yoshioka H, et al. 2021. Front Cell Dev Biol. 9:621045. PubMed
  44. Yang Y, et al. 2021. Metabolism. 123:154863. PubMed
  45. Sun X, et al. 2022. JCI Insight. 7: . PubMed
  46. Coray M, et al. 2022. Int J Mol Sci. 23:. PubMed
  47. He Y, et al. 2020. Nat Commun. 11:1996. PubMed
  48. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  49. Ren Q, et al. 2013. PLoS One. 8:74732. PubMed
  50. Zhang W, et al. 2021. J Clin Invest. 131:. PubMed
  51. Ambrosi TH, et al. 2021. Elife. 10: . PubMed
  52. Zeng H, et al. 2018. Cancer Cell. 34:56:00. PubMed
  53. Lei W, et al. 2020. Sci Rep. 10:7004. PubMed
  54. Wang Y, et al. 2019. Cell. 179:1144. PubMed
  55. Zhang M, et al. 2017. Oncol Lett. 3.069444444. PubMed
  56. Schrier S, et al. 2016. Sci Rep. 6:34942. PubMed
  57. O'Neill K, et al. 2016. Genes Dev. 30: 973-988. PubMed
  58. Sapanidou V, et al. 2015. Theriogenology. . PubMed
  59. Kong S, et al. 2014. J Immunol. 193:5515. PubMed
  60. Zou PA, et al. 2021. Oncol Lett. 22:648. PubMed
  61. Masuda T, et al. 2022. iScience. 25:104781. PubMed
  62. Chen C, et al. 2019. Cell Rep. 29:4200. PubMed
  63. Liu L, et al. 2019. Cell Prolif. :e12718. PubMed
  64. Feng L, et al. 2016. J Cell Sci. 129: 2202 - 2212. PubMed
  65. Lange N, et al. 2016. PLoS One. 11: 0160843. PubMed
  66. Jordan PM, et al. 2020. Cell Rep. 33:108247. PubMed
  67. Liu Y, et al. 2017. Acta Biomater. 10.1016/j.actbio.2017.08.021. PubMed
  68. Reighard SD, et al. 2020. Cell Rep Med. :1. PubMed
  69. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  70. Xu B, et al. 2016. Leukemia. 10.1038/leu.2016.297. PubMed
  71. Yang M, et al. 2021. Med Sci Monit. 27:e930083. PubMed
  72. Domenis R, et al. 2017. PLoS One. 10.1371/journal.pone.0169932. PubMed
  73. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  74. Matsuda K, et al. 2021. Cell Rep Methods. 1:100122. PubMed
  75. Pang K, et al. 2022. Cell Death Dis. 13:169. PubMed
  76. Tang X, et al. 2021. Transl Cancer Res. 10:2120. PubMed
  77. Liu H, et al. 2020. Cell Death Dis. 0.767361111. PubMed
  78. Li L, et al. 2018. Oncol Lett. 4.184722222. PubMed
  79. Jung E, et al. 2017. J Neurosci. 37:6837. PubMed
  80. Basso-Ricci L, et al. 2017. Cytometry A. 10.1002/cyto.a.23148. PubMed
  81. Zhang X, et al. 2020. Eur J Med Chem. 112186:192. PubMed
  82. Mensen A, et al. 2015. Biol Blood Marrow Transplant. Available online 10 August 2015. PubMed
  83. Zhao W, et al. 2013. Clin Immunol. 149:119. PubMed
  84. Shanahan MT, et al. 2021. Am J Physiol Gastrointest Liver Physiol. 321:G668. PubMed
  85. Wang J, et al. 2022. J Clin Invest. :. PubMed
  86. Trudu M, et al. 2022. Front Oncol. 12:968208. PubMed
  87. Litzenburger UM, et al. 2017. Genome Biol. 18:15. PubMed
  88. Li Y, et al. 2016. Int J Lower Extrem Wounds. 10.1177/1534734616649485. PubMed
  89. Hu D, et al. 2020. Proc Natl Acad Sci U S A. 117:30639. PubMed
  90. Li Q, et al. 2020. Acta Biochim Biophys Sin (Shanghai). 52:1131. PubMed
  91. Moribe F, et al. 2021. PLoS One. 16:e0237554. PubMed
  92. Xue G, et al. 2021. Nat Biomed Eng. 5:1306. PubMed
  93. Lasrado N, et al. 2022. iScience. 25:103865. PubMed
  94. Perl AL, et al. 2019. J Biol Chem. 294:17043. PubMed
  95. Diaz Osterman CJ, et al. 2019. Elife. 8:e47327. PubMed
  96. Hosokawa T, et al. 2017. J Immunol. 10.4049/jimmunol.1700157. PubMed
  97. El-Hafeez A, et al. 2017. Cytotechnology. 10.1007/s10616-017-0124-1. PubMed
  98. L Chang, Y Li, D Kaplan 2016. Sci Rep. 6:36862. PubMed
  99. Tsou W, et al. 2014. J Biol Chem. 289:25750. PubMed
  100. Oubaha M, et al. 2016. Sci Transl Med. 8: 362ra144. PubMed
  101. Polk A, et al. 2016. Clin Cancer Res. 22(24):6118-6128. PubMed
  102. Pal P, et al. 2021. J Med Chem. 64:14230. PubMed
  103. Hedemann N, et al. 2021. Cancers (Basel). 13:. PubMed
  104. Xie B, et al. 2021. J Immunol. 206:1515. PubMed
  105. El-Hafeez A, et al. 2017. Cytotechnology. 10.1007/s10616-017-0116-1. PubMed
  106. Xie M, et al. 2017. BMC Cancer . 10.1186/s12885-017-3291-8. PubMed
  107. Harro CM, et al. 2020. J Clin Invest. . PubMed
  108. Imura Y, et al. 2020. JCI Insight. :5. PubMed
  109. Suzuki S, et al. 2021. STAR Protocols. 2:100683. PubMed
  110. Vickman R, et al. 2016. Mol Cancer Res. 14: 776 - 786. PubMed
  111. Matsubara T, et al. 2022. J Exp Med. 219:. PubMed
  112. Huang K, et al. 2018. Biol Open. 7:bio029470. PubMed
  113. Wang H, et al. 2019. Nat Commun. 4.388194444. PubMed
  114. M H, et al. 2016. Cell Transplant. 25: 811-27. PubMed
  115. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  116. Viereckl MJ, et al. 2022. Biomolecules. 12:. PubMed
  117. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  118. Liu X, et al. 2019. Mol Cancer Ther. 18:706. PubMed
  119. Yang X, et al. 2017. J Control Release. 10.1016/j.jconrel.2017.07.014. PubMed
  120. Hughes K, et al. 2017. Open Bio. 10.1098/rsob.160155. PubMed
  121. Resch U, et al. 2016. MBio. 7: e00207-16. PubMed
  122. Bao W, et al. 2016. Sci Rep. 6:22579. PubMed
  123. Ghura H, et al. 2021. Neoplasia. 23:837. PubMed
  124. Bjørnstad R, et al. 2019. Mol Cancer Ther. 1.14375. PubMed
  125. Beggs K, et al. 2014. Toxicol Sci. 137:91. PubMed
  126. Wang C, et al. 2017. Drug Deliv. 10.1080/10717544.2017.1293195. PubMed
  127. Nilsri N, et al. 2021. Sci Rep. 5255:11. PubMed
  128. Widodo N, et al. 2022. F1000Res. 11:169. PubMed
  129. Tu Z, et al. 2022. Cell Rep. 40:111072. PubMed
  130. Bensberg M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  131. He Y, et al. 2020. J Hematol Oncol. 0.607638889. PubMed
  132. Goel S, et al. 2021. Nat Commun. 12:5325. PubMed
  133. Szeto C, et al. 2022. Nat Commun. 13:4951. PubMed
  134. Siddhartha V, et al. 2017. Artif Cells Nanomed Biotechnol . 10.1080/21691401.2017.1313267. PubMed
  135. Viseshakul N, et al. 2017. Parasitol Res. 10.1007/s00436-017-5589-5. PubMed
  136. Chmielewski M and Abken H 2017. Cell Rep.. 10.1016/j.celrep.2017.11.063. PubMed
  137. Sakimoto I, et al. 2006. Cancer Res. 66:2287. PubMed
  138. Namas R, et al. 2016. Lupus Sci Med. 3: e000148. PubMed
  139. Chen Y, et al. 2016. J Biol Chem. 291: 13216 - 13228. PubMed
  140. Deng BB, et al. 2020. Cell Biol Int. 44:1890. PubMed
  141. Vulin M, et al. 2022. Oncogene. :. PubMed
  142. Popa S, et al. 2020. Wellcome Open Res. 0.249305556. PubMed
  143. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  144. Mahmoudi M, et al. 2016. Sci Rep. 6:26960. PubMed
  145. Juel H, et al. 2013. PLoS One. 8:64619. PubMed

Antigen Details

Biology Area
Cell Biology, Cell Cycle/DNA Replication, Neuroscience
Gene ID
NA

Related FAQs

Why is washing not recommended after the addition 7-AAD or PI addition when assessing viability?

These dyes bind in equilibrium with DNA. Therefore, external dye concentration must be maintained during analysis and the dye should not be washed out.

Go To Top Version: 2    Revision Date: 10/08/2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account